David
Santamaría Velilla
University of Texas Southwestern Medical Center
Dallas, Estados UnidosUniversity of Texas Southwestern Medical Center-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2018
-
KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS
Cell, Vol. 172, Núm. 4, pp. 857-868.e15